ERAS Competitors & Alternatives
Compare Erasca Inc with similar stocks in the same industry
Biotechnology
ERAS
Main Stock$15.07
Tradestie Score
60
Market Cap
$626.91M
Analyst Upside
+39.3%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TGTX
TG Therapeutics, Inc.
|
$53.94
|
$5.80B | 19.0 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$340.21
|
$5.20B | 46.2 | 60 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$51.96
|
$4.94B | - | 60 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$82.13
|
$4.93B | - | 56 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$79.90
|
$4.84B | - | 62 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$118.96
|
$3.98B | - | 66 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$35.91
|
$3.92B | - | 61 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$98.25
|
$3.91B | - | 62 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$18.49
|
$3.83B | - | 54 | Compare |
More ERAS Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry